deltatrials
Recruiting PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT05535738

Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation

Biologics and Blistering - Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation Through Suction Blistering

Sponsor: Wei-Che Ko

Updated 8 times since 2022 Last updated: Nov 12, 2025 Started: Nov 15, 2022 Primary completion: Jan 1, 2027 Completion: Dec 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Allergic Contact Dermatitis and Skin Inflammation and is currently actively recruiting participants. Wei-Che Ko leads this study, which shows 8 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Sep 2022 – ~Jul 2023 · 10 months · monthly snapshotRecruiting~Jul 2023 – ~Jun 2024 · 11 months · monthly snapshotRecruiting~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Jul 2025 · 10 months · monthly snapshotRecruiting~Jul 2025 – ~Nov 2025 · 4 months · monthly snapshotRecruiting~Nov 2025 – ~Dec 2025 · 30 days · monthly snapshotRecruiting~Dec 2025 – present · 9 months · monthly snapshotRecruiting

Change History

8 versions recorded
  1. Dec 2025 — Present [monthly]

    Recruiting PHASE2/PHASE3

  2. Nov 2025 — Dec 2025 [monthly]

    Recruiting PHASE2/PHASE3

  3. Jul 2025 — Nov 2025 [monthly]

    Recruiting PHASE2/PHASE3

  4. Sep 2024 — Jul 2025 [monthly]

    Recruiting PHASE2/PHASE3

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2/PHASE3

    Phase: PHASE2_PHASE3PHASE2/PHASE3

Show 3 earlier versions
  1. Jun 2024 — Jul 2024 [monthly]

    Recruiting PHASE2_PHASE3

  2. Jul 2023 — Jun 2024 [monthly]

    Recruiting PHASE2_PHASE3

  3. Sep 2022 — Jul 2023 [monthly]

    Recruiting PHASE2_PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Wei-Che Ko
Data source: University of Massachusetts, Worcester

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations